Mustang Bio appoints Eliot M. Lurier as Interim CFO via Danforth Advisors

MUSTANG BIO, INC.

Eliot M. Lurier, age 63, appointed Interim CFO effective April 18, 2022; he is a consultant from Danforth Advisors.
Lurier will serve as principal financial officer under a consulting agreement with Danforth; he receives no direct compensation from Mustang.
Prior to Danforth, Lurier was CFO of Joslin Diabetes Center (2014-2020); he holds a B.S. in Accounting and is a CPA.
No family relationships or transactions requiring disclosure exist between Lurier and Mustang's directors or officers.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Eliot M. Lurier

Interim Chief Financial Officer

MBIO · MUSTANG BIO, INC.

Effective: 2022-04-18
Filed: April 22, 2022, 7:59 PM ET

On April 18, 2022, Mustang Bio, Inc. (the “Company”) appointed Eliot M. Lurier as the Company’s Interim Chief Financial Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eliot M. Lurier was appointed as Interim Chief Financial Officer at MUSTANG BIO, INC..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On April 18, 2022, Mustang Bio, Inc. (the “Company”) appointed Eliot M. Lurier as the Company’s Interim Chief Financial Officer.

View on SEC.gov

MUSTANG BIO, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-048968

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.